The Impact of Quarantine and Physical Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric Italian Population Trial.

anxiety burn-out depression global mental health pandemic post-traumatic stress disorder resilience

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2020
Historique:
received: 17 04 2020
accepted: 26 05 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 26 6 2020
Statut: epublish

Résumé

The COVID-19 pandemic and its related containment measures-mainly physical distancing and isolation-are having detrimental consequences on the mental health of the general population worldwide. In particular, frustration, loneliness, and worries about the future are common reactions and represent well-known risk factors for several mental disorders, including anxiety, affective, and post-traumatic stress disorders. The vast majority of available studies have been conducted in China, where the pandemic started. Italy has been severely hit by the pandemic, and the socio-cultural context is completely different from Eastern countries. Therefore, there is the need for methodologically rigorous studies aiming to evaluate the impact of COVID-19 and quarantine measures on the mental health of the Italian population. In fact, our results will help us to develop appropriate interventions for managing the psychosocial consequences of pandemic. The "COVID-IT-mental health trial" is a no-profit, not-funded, national, multicentric, cross-sectional population-based trial which has the following aims: a) to evaluate the impact of COVID-19 pandemic and its containment measures on mental health of the Italian population; b) to identify the main areas to be targeted by supportive long-term interventions for the different categories of people exposed to the pandemic. Data will be collected through a web-platform using validated assessment tools. Participants will be subdivided into four groups: a) Group 1-COVID-19 quarantine group. This group includes the general population which are quarantined but not isolated, i.e., those not directly exposed to contagion nor in contact with COVID-19+ individuals; b) Group 2-COVID-19+ group, which includes isolated people directly/indirectly exposed to the virus; c) Group 3-COVID-19 healthcare staff group, which includes first- and second-line healthcare professionals; d) Group 4-COVID-19 mental health, which includes users of mental health services and all those who had already been diagnosed with a mental disorder. Mental health services worldwide are not prepared yet to manage the short- and long-term consequences of the pandemic. It is necessary to have a clear picture of the impact that this new stressor will have on mental health and well-being in order to develop and disseminate appropriate interventions for the general population and for the other at-risk groups.

Identifiants

pubmed: 32581895
doi: 10.3389/fpsyt.2020.00533
pmc: PMC7290062
doi:

Types de publication

Journal Article

Langues

eng

Pagination

533

Informations de copyright

Copyright © 2020 Giallonardo, Sampogna, Del Vecchio, Luciano, Albert, Carmassi, Carrà, Cirulli, Dell’Osso, Nanni, Pompili, Sani, Tortorella, Volpe and Fiorillo.

Références

Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):405-12
pubmed: 19479171
World Psychiatry. 2019 Feb;18(1):101-102
pubmed: 30600628
World Psychiatry. 2018 Jun;17(2):230-231
pubmed: 29856569
Int Rev Psychiatry. 2018 Apr;30(2):169-175
pubmed: 29757031
Brain Behav Immun. 2020 Aug;88:916-919
pubmed: 32169498
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Glob Ment Health (Camb). 2020 Feb 11;7:e6
pubmed: 32180989
BMJ Open. 2019 Jun 28;9(6):e029342
pubmed: 31256037
World Psychiatry. 2020 Feb;19(1):38-39
pubmed: 31922686
Psychol Med. 2004 Oct;34(7):1197-204
pubmed: 15697046
Acta Psychiatr Scand. 2020 May;141(5):479-480
pubmed: 32279309
Psychiatry Clin Neurosci. 2020 Apr;74(4):281-282
pubmed: 32034840
Am Psychol. 2009 Sep;64(6):527-37
pubmed: 19739882
Suicide Life Threat Behav. 2014 Aug;44(4):408-19
pubmed: 24612048
JAMA Intern Med. 2020 Jun 1;180(6):817-818
pubmed: 32275292
CMAJ. 2003 May 13;168(10):1245-51
pubmed: 12743065
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
J Pers Assess. 1987 Spring;51(1):69-81
pubmed: 3572711
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
J Trauma Stress. 2005 Feb;18(1):39-42
pubmed: 16281194
World Psychiatry. 2019 Jun;18(2):119-129
pubmed: 31059635
J Psychol. 1975 Sep;91(1):93-114
pubmed: 28136248
Epidemiol Psichiatr Soc. 2009 Apr-Jun;18(2):137-46
pubmed: 19526745
J Psychosom Res. 2006 May;60(5):513-9
pubmed: 16650592
J Psychosom Res. 2010 Feb;68(2):195-202
pubmed: 20105703
World Psychiatry. 2018 Oct;17(3):243-257
pubmed: 30192087
J Psychiatr Res. 2007 Jan-Feb;41(1-2):119-30
pubmed: 16460760
Compr Psychiatry. 2015 Jul;60:170-81
pubmed: 25933937
Curr Opin Psychol. 2020 Apr;32:105-109
pubmed: 31445427
J Affect Disord. 2015 Feb 1;172:291-9
pubmed: 25451428
World Psychiatry. 2018 Oct;17(3):367-368
pubmed: 30192105
Ann Gen Psychiatry. 2018 May 04;17:17
pubmed: 29755579
Psychiatry Investig. 2020 Feb;17(2):85-86
pubmed: 32093458
Psychol Assess. 2002 Dec;14(4):485-96
pubmed: 12501574
World Psychiatry. 2018 Jun;17(2):226-227
pubmed: 29856556
Front Psychiatry. 2020 Feb 11;11:1
pubmed: 32116830
Eur Psychiatry. 2020 Apr 01;63(1):e32
pubmed: 32234102
Psychiatry Res. 2020 May;287:112915
pubmed: 32199182
World Psychiatry. 2018 Feb;17(1):40-41
pubmed: 29352550
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
World Psychiatry. 2018 Feb;17(1):30-38
pubmed: 29352529
Front Psychiatry. 2018 Jun 07;9:235
pubmed: 29930520
World Psychiatry. 2019 Feb;18(1):20-28
pubmed: 30600624
World Psychiatry. 2018 Oct;17(3):277-278
pubmed: 30192097
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Psychol Med. 2021 Apr;51(6):1052-1053
pubmed: 32216863
Lancet Psychiatry. 2020 Mar;7(3):e14
pubmed: 32035030
Psychiatry Clin Neurosci. 2020 Jun;74(6):372
pubmed: 32248608
World Psychiatry. 2019 Feb;18(1):111-112
pubmed: 30600627
Perspect Psychol Sci. 2018 Jan;13(1):70-87
pubmed: 28937910
World Psychiatry. 2019 Oct;18(3):259-269
pubmed: 31496089
World Psychiatry. 2019 Oct;18(3):325-336
pubmed: 31496095
Int J Environ Res Public Health. 2020 Mar 31;17(7):
pubmed: 32244498
Psychiatry Res. 2020 Jun;288:112936
pubmed: 32276196
Psychol Health Med. 2021 Jan;26(1):23-34
pubmed: 32286091
World Psychiatry. 2019 Jun;18(2):236-237
pubmed: 31059609
Psychiatry Clin Neurosci. 2006 Aug;60(4):397-403
pubmed: 16884438
Front Psychiatry. 2019 Feb 13;10:55
pubmed: 30814962
World Psychiatry. 2018 Oct;17(3):276-277
pubmed: 30192103
Anxiety Stress Coping. 2010;23(2):127-37
pubmed: 19582640
Int Rev Psychiatry. 2019 Nov - Dec;31(7-8):569-573
pubmed: 31469033
JAMA. 2015 Oct 20;314(15):1637-8
pubmed: 26501539
BMJ. 2020 Apr 6;369:m1379
pubmed: 32253182
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Emerg Infect Dis. 2020 Jul;26(7):1616-1618
pubmed: 32202993
J Pers Assess. 1990 Winter;55(3-4):610-7
pubmed: 2280326
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Neuropsychiatr Dis Treat. 2016 Feb 18;12:375-81
pubmed: 26937192
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
BMC Med Res Methodol. 2020 Mar 23;20(1):70
pubmed: 32293286
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Front Public Health. 2014 Dec 22;2:286
pubmed: 25566527
BMJ. 2020 Jan 28;368:m313
pubmed: 31992552
CNS Neurol Disord Drug Targets. 2017;16(8):857
pubmed: 29474168
World Psychiatry. 2019 Feb;18(1):97-98
pubmed: 30600619
Can J Psychiatry. 2007 Apr;52(4):233-40
pubmed: 17500304

Auteurs

Vincenzo Giallonardo (V)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Gaia Sampogna (G)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Valeria Del Vecchio (V)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Mario Luciano (M)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Umberto Albert (U)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Department of Mental Health, Azienda Sanitaria Universitaria Giuliano Isontina - ASUGI, Trieste, Italy.

Claudia Carmassi (C)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Giuseppe Carrà (G)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Francesca Cirulli (F)

Center for Behavioral Sciences and Mental Health, National Institute of Health, Rome, Italy.

Bernardo Dell'Osso (B)

Department of Biomedical and Clinical Sciences Luigi Sacco, Aldo Ravelli Center for Neurotechnology and Brain Therapeutic, University of Milan, Milan, Italy.

Maria Giulia Nanni (MG)

Department of Biomedical and Specialty Surgical Sciences, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.

Maurizio Pompili (M)

Department of Neurosciences, Mental Health and Sensory Organs, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.

Gabriele Sani (G)

Section of Psychiatry, Department of Neuroscience, University Cattolica del Sacro Cuore, Rome, Italy.
Department of Psychiatry, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.

Alfonso Tortorella (A)

Department of Psychiatry, University of Perugia, Perugia, Italy.

Umberto Volpe (U)

Clinical Psychiatry Unit, Department of Clinical Neurosciences, Università Politecnica delle Marche, Ancona, Italy.

Andrea Fiorillo (A)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Classifications MeSH